Aging mice have increased chromosome instability that is exacerbated by elevated Mdm2 expression
Open accessAbstract
Aging is thought to negatively affect multiple cellular processes including the ability to maintain chromosome stability. Chromosome instability (CIN) is a common property of cancer cells and may be a contributing factor to cellular transformation. The types of DNA aberrations that arise during aging before tumor development and that contribute to tumorigenesis are currently unclear. Mdm2, a key regulator of the p53 tumor suppressor and modulator of DNA break repair, is frequently overexpressed in malignancies and contributes to CIN. To determine the relationship between aging and CIN and the role of Mdm2, precancerous wild-type C57Bl/6 and littermate-matched Mdm2 transgenic mice at various ages were evaluated. Metaphase analyses of wild-type cells showed a direct correlation between age and increased chromosome and chromatid breaks, chromosome fusions and aneuploidy, but the frequency of polyploidy remained stable over time. Elevated levels of Mdm2 in precancerous mice increased both the numerical and the structural chromosomal abnormalities observed. Chromosome and chromatid breaks, chromosome fusions, aneuploidy and polyploidy were increased in older Mdm2 transgenic mice compared with wild-type littermates. Unexpectedly, chromosome fusions, aneuploidy and polyploidy rates in Mdm2 transgenic mice, but not chromosome and chromatid breaks, showed cooperation between Mdm2 overexpression and age. Notably, Mdm2 overexpression promoted gains in one or more chromosomes with age, while it did not affect the rate of chromosome loss. Therefore, aging increased specific forms of genomic instability, and elevated Mdm2 expression cooperated with aging to increase the likelihood of gaining certain chromosomal abnormalities of the kind thought to lead to cancer development.
AI snapshot
Written from the paper’s full text.
TL;DR
Aging wild-type C57Bl/6 mice showed increased chromosome instability, and elevated Mdm2 expression in pre-cancerous Mdm2 transgenic littermates exacerbated several age-related chromosomal abnormalities. Mdm2 overexpression particularly cooperated with age to increase chromosome fusions, aneuploidy, polyploidy, and gains of chromosomes, but not chromosome loss.
Key findings
- In approximately 3,600 metaphase spreads from 72 littermate-matched wild-type and Mdm2 hemizygous transgenic mice aged 2–14 months, Mdm2 transgenic mice had a marked age-related increase in total chromosomal abnormalities (p<0.0005); at 14 months the number of chromosomal abnormalities in Mdm2 transgenic mice was twice that in wild-type mice.
- Chromosome and chromatid breaks were significantly higher in Mdm2 transgenic mice than wild-type mice at all ages evaluated (p=0.001), but the rate of increase in breaks with age was statistically similar between genotypes (p=0.49).
- Chromosome fusions were more frequent in Mdm2 transgenic mice, with the greatest difference at older ages (p=0.05); 66% of fusions in both genotypes were centromeric-centromeric Robertsonian translocations, about a quarter were centromeric-telomeric, and less than 10% were telomeric-telomeric.
- Polyploid metaphases with 50–80 chromosomes increased significantly with age in Mdm2 transgenic mice (p=0.04) but remained relatively constant in wild-type mice; aneuploidy increased in wild-type mice (p=0.04) and more strongly in Mdm2 transgenic mice (p<0.0005), with Mdm2 transgenic mice having more than twice the mean aneuploid cells at 14 months versus 2 months.
- Chromosome loss increased with age in both genotypes (p=0.003) at a similar rate (p=0.88), whereas chromosome gain increased significantly only in Mdm2 transgenic mice (p=0.003), with triple the mean number of metaphases with >40 chromosomes at 14 months compared to 2 months.
Methods
- Pre-cancerous wild-type C57Bl/6 and littermate-matched Mdm2 hemizygous transgenic mice expressing Mdm2 under its native promoter were sacrificed at 2, 5, 8, 10, 12, and 14 months; mice older than 14 months were excluded due to tumor development in Mdm2 transgenic mice, and mice with overt or suspected malignancy were excluded.
- Splenocytes were stimulated to mitosis, metaphase spreads were prepared, stained with propidium iodide and DAPI, blinded, and 48–52 metaphases per mouse per genotype per age were visualized and photographed; chromosome abnormalities and chromosome numbers were scored.
- Statistical analysis used multiple linear regression for total abnormalities and negative binomial regression for event rates, including genotype, age, and genotype-by-age interaction terms, with the log number of evaluated metaphases as an offset; GEE models were used as sensitivity analyses and gave similar results.
Limitations
- The paper states that mice older than 14 months were excluded because of tumor development in Mdm2 transgenic mice, and any mouse with overt cancer or suspected malignancy was excluded from the study.
- The paper does not include a dedicated limitations section; evident from the text, the study is limited to splenocytes from a single Mdm2 transgenic mouse model, so findings may not generalize to other tissues, other Mdm2 expression models, or humans.
- The study reports associations between age, Mdm2 overexpression, and chromosomal abnormalities but does not directly establish the mechanisms by which Mdm2 overexpression leads to specific abnormalities such as chromosome gains versus losses.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 28 cited sources checked · 0 supported · 0 flagged
- Findingown data
In Mdm2 transgenic mice, chromosome instability increases markedly with age.
“In contrast, Mdm2 transgenic mice had a marked increase in CIN with increasing age (p<0.0005).”
Quote in the paperSubstantial claim - Findingown data
Mdm2 transgenic mice have triple the mean number of metaphases with greater than 40 chromosomes at 14 months compared to at 2 months of age.
“Mdm2 transgenic mice had triple the mean number of metaphases with greater than 40 chromosomes at 14 months old compared to at 2 months of age.”
Quote in the paperSubstantial claim - Findingown data
Severe structurally abnormal chromosomes are detected only in pre-cancerous cells from Mdm2 transgenic mice, not in wild-type cells.
“Moreover, severe structurally abnormal chromosomes were only detected in pre-cancerous cells in Mdm2 transgenics and not in wild-type cells.”
Quote in the paperNot a substantial claim - Findingown data
Mdm2 transgenic mice have cells containing more than 4N DNA.
“Furthermore, Mdm2 transgenic mice also had cells that contained more than 4N DNA (Fig. 4E).”
Quote in the paperSubstantial claim - Findingown data
Aging Mdm2 transgenic mice have a large significant, non-linear increase in aneuploid cells, with the mean number at 14 months more than twice that at 2 months (p<0.0005).
“Notably, aging Mdm2 transgenic mice had a large significant, non-linear increase in aneuploid cells such that the mean number of aneuploid cells in mice 14 months old was more than twice that in mice 2 months old (p<0.0005) (Fig. 5D).”
Quote in the paperSubstantial claim
- Findingown data
All chromosomal alterations in both wild-type and Mdm2 transgenic mice occurred prior to overt tumor development.
“Importantly, all chromosomal alterations in both wild-type and Mdm2 transgenic mice occurred prior to overt tumor development”
Quote in the paperSubstantial claim - Findingown data
The rate of increase of DNA breaks with age is statistically similar between wild-type and Mdm2 transgenic cells (p=0.49).
“Surprisingly, the rate of increase of DNA breaks with age was statistically similar between wild-type and Mdm2 transgenic cells (p=0.49).”
Quote in the paperSubstantial claim - Findingown data
Wild-type and Mdm2 transgenic mice have a similar number of metaphases with less than 40 chromosomes at all ages evaluated.
“Unexpectedly, wild-type and Mdm2 transgenic mice had a similar number of metaphases with less than 40 chromosomes at all ages evaluated.”
Quote in the paperSubstantial claim - Findingown data
Overexpression of Mdm2 results in an increase in all measures of genome instability except the loss of chromosomes.
“Interestingly, overexpression of Mdm2 resulted in an increase in all measures of genome instability, except the loss of chromosomes.”
Quote in the paperSubstantial claim - Findingown data
Polyploid metaphases are detected in both wild-type and Mdm2 transgenic mice.
“Polyploid metaphases (40 chromosomes is normal) were detected in both wild-type and Mdm2 transgenic mice (Fig. 4A–4C).”
Quote in the paperNot a substantial claim - Findingown data
In both wild-type and Mdm2 transgenic mice, chromosome breaks are more common than chromatid breaks.
“Both chromatid and chromosome breaks were detected in wild-type and Mdm2 transgenic mice with chromosome breaks dominating in both genotypes (Fig. 2A–2C).”
Quote in the paperNot a substantial claim - Findingown data
At 2 months of age, a higher percentage of metaphases from Mdm2 transgenic mice have chromosome and chromatid breaks compared to wild-type littermates.
“at 2 months old, a higher percentage of metaphases from Mdm2 transgenic mice had chromosome and chromatid breaks compared to metaphases from wild-type littermates.”
Quote in the paperSubstantial claim - Findingown data
At two months of age, the number of metaphases with 50-80 chromosomes is similar for wild-type and Mdm2 transgenic littermates.
“At two months of age, the number of metaphases with 50–80 chromosomes was similar for wild-type and Mdm2 transgenic littermates (Fig. 4C & 4D).”
Quote in the paperNot a substantial claim - Findingown data
Tri-radial chromosomes are observed in Mdm2 transgenic mice but not in wild-type mice.
“Moreover, tri-radial chromosomes, which are usually due to increased mitotic recombination, were observed in Mdm2 transgenic mice, but not in wild-type mice.”
Quote in the paperSubstantial claim - Findingown data
Most fusions (66%) in both genotypes are centromeric-centromeric Robertsonian translocations.
“Most (66%) of the fusions identified for both genotypes were centromeric-centromeric fusions also known as Robertsonian translocations (Fig. 3A & 3B)”
Quote in the paperNot a substantial claim - Findingown data
In wild-type C57Bl/6 mice, the total number of chromosomal abnormalities increases gradually with age.
“There was a small, gradual increase in the total number of chromosomal abnormalities in wild-type mice as they aged (Fig. 1A and 1B).”
Quote in the paperSubstantial claim - Findingown data
At 14 months of age, Mdm2 transgenic mice have twice the number of chromosomal abnormalities as wild-type mice.
“but at 14 months old the number of chromosomal abnormalities in Mdm2 transgenic mice was twice that in wild-type mice (Fig. 1B).”
Quote in the paperSubstantial claim - Findingown data
The mean number of metaphases with DNA breaks is significantly higher in Mdm2 transgenic mice than in wild-type mice at all ages evaluated (p=0.001).
“The mean number of metaphases with DNA breaks was significantly higher for Mdm2 transgenic mice compared to wild-type mice at all ages evaluated (p=0.001) (Fig. 2D).”
Quote in the paperSubstantial claim - Findingown data
Tri-radial chromosomes are detected only in Mdm2 transgenic cells, not in wild-type cells.
“Moreover, tri-radial chromosomes, which lead to DNA breaks, were detected only in Mdm2 transgenic cells (Fig. 2E).”
Quote in the paperNot a substantial claim - Findingown data
At 2 months of age, wild-type and Mdm2 transgenic mice have similar frequencies of chromosomal abnormalities.
“The frequency of chromosomal abnormalities in wild-type and Mdm2 transgenic mice were similar at 2 months of age”
Quote in the paperSubstantial claim - Findingnone given
The number of cells losing one or more chromosomes increases at a similar rate with age in both wild-type and Mdm2 transgenic mice.
“Surprisingly, the number of cells losing one or more chromosomes increased at a similar rate with age in both wild-type and Mdm2 transgenic mice.”
Quote in the paperSubstantial claim - Findingown data
Both genotypes show a similar rate of increase in metaphases with less than 40 chromosomes over 14 months (p=0.88).
“Consequently, both genotypes of mice showed a similar rate of increase in metaphases with less than 40 chromosomes over 14 months (p=0.88) (Fig. 6B).”
Quote in the paperSubstantial claim - Findingown data
Metaphases with greater than or less than the normal number of 40 chromosomes are detected in both wild-type and Mdm2 transgenic mice.
“Metaphases with greater than or less than the normal number of 40 chromosomes were detected in both wild-type and Mdm2 transgenic mice (Fig. 5A & 5B)”
Quote in the paperSubstantial claim - Findingown data
The number of metaphases with breaks gradually increases with age in both wild-type and Mdm2 transgenic mice.
“The number of metaphases with breaks gradually increased with age for both wild-type and Mdm2 transgenic mice (Fig. 2D).”
Quote in the paperSubstantial claim - Findingown data
The rate of increase in metaphases with more than 40 chromosomes over 14 months is greater in Mdm2 transgenic mice than in wild-type mice.
“In contrast, the rate of increase in metaphases with more than 40 chromosomes over 14 months was greater in Mdm2 transgenic mice than wild-type mice (Fig. 6C & 6D).”
Quote in the paperSubstantial claim - Findingown data
As wild-type mice age, they show a small but steady, significant increase in the number of aneuploid metaphases (p=0.04).
“As wild-type mice aged, they showed a small but steady, significant increase in the number of metaphases that were aneuploid (Fig. 5D, p=0.04).”
Quote in the paperSubstantial claim - Findingown data
At 2 months of age, there are slightly more metaphases from Mdm2 transgenic mice with greater than 40 chromosomes compared to wild-type mice.
“At 2 months of age there were slightly more metaphases from Mdm2 transgenic mice that had greater than 40 chromosomes compared to wild-type mice.”
Quote in the paperNot a substantial claim - Findingown data
Metaphases with multiple chromosomes fused end-to-end and ring chromosomes are detected in Mdm2 transgenic mice as young as 5 months old.
“Metaphases with multiple chromosomes fused end-to-end and ring chromosomes were detected in Mdm2 transgenic mice as young as 5 months old.”
Quote in the paperSubstantial claim - Findingreasoning
There is an increase in chromosomal fusions that correlates with age in both wild-type and Mdm2 transgenic mice.
“In accordance with the rate of breaks, there was an increase in chromosomal fusions that correlated with age in both the wild-type and the Mdm2 transgenic mice.”
Quote in the paperSubstantial claim - Findingown data
Mdm2 overexpression results in severe structural chromosome fusion abnormalities that are not observed in wild-type mice.
“Notably, Mdm2 overexpression resulted in severe structural chromosome fusion abnormalities that were not observed in wild-type mice.”
Quote in the paperSubstantial claim - Interpretationown data
Mdm2 overexpression appears to accelerate the rate of aneuploidy development with age compared to wild-type mice.
“Therefore, Mdm2 overexpression appeared to accelerate the rate of aneuploidy development with age compared to wild-type mice.”
Quote in the paperSubstantial claim - Interpretationreasoning
There are multiple pathways to tetraploidy mediated by Mdm2 expression that explain the increased polyploidy in Mdm2 transgenic mice.
“Therefore, there are multiple pathways to tetraploidy mediated by Mdm2 expression to explain the increased polyploidy in Mdm2 transgenic mice.”
Quote in the paperSubstantial claim - Interpretationreasoning
The polyploidy observed in Mdm2 transgenic cells is likely due at least in part to inhibition of p53 by Mdm2.
“Since Mdm2 negatively regulates p53 (Marine and Lozano, 2010), and p53 inhibits the development of tetraploidy (Fujiwara et al., 2005, Ganem et al., 2007, Storchova and Kuffer, 2008, Thompson et al., 2010, Vitale et al., 2010), the polyploidy we observed in Mdm2 transgenic cells is likely due at least in part to inhibition of p53 by Mdm2.”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Loss of p53 function is important for the proliferation of aneuploid cells.
“Recently, loss of p53 function was found to be important for the proliferation of aneuploid cells (Thompson and Compton, 2010)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Thompson and Compton, 2010
Not checked in the free run.
- Interpretationown data
There is a greater likelihood of gaining partial or whole genomes as mice age if Mdm2 is overexpressed.
“Thus, there was a greater likelihood of gaining partial or whole genomes as mice aged, if Mdm2 was overexpressed.”
Quote in the paperSubstantial claim - Interpretationreasoning
Mdm2 may influence polyploidy through regulation of Nbs1.
“In addition, Mdm2 also negatively regulates the DNA repair protein, Nbs1 (Alt et al., 2005, Bouska et al., 2008). Nbs1 has a role in preventing endoreduplication (Wu et al., 2004), which leads to polyploidy, suggesting that Mdm2 may influence polyploidy through the regulation of Nbs1 as well.”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
There is a decrease in p53 function with age.
“Similarly, there is a decrease in p53 function with age (Feng et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Feng et al., 2007 source
Not checked in the free run.
- Premisecitation
In primary B cells from young mice, Mdm2 overexpression leads to an increase in DNA breaks and aneuploidy.
“We previously showed that in primary B cells in young mice, Mdm2 overexpression leads to an increase in DNA breaks and aneuploidy (Wang et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wang et al., 2008 source
Not checked in the free run.
- Premisecitation
The expression and activity of DNA repair enzymes decrease with age.
“Specifically, the expression and activity of DNA repair enzymes decrease with age.”
Quote in the paperSubstantial claim
- May combine two claims. 31
- Classified as probably not a substantial claim. 13
May combine two claims.
Findingown dataThe rate of increase in chromatid and chromosome breaks in aging mice is similar between wild-type and Mdm2 transgenic mice, although Mdm2 transgenic cells have more DNA breaks at every age evaluated.
“Unexpectedly, the rate of increase in chromatid and chromosome breaks in aging mice was similar between wild-type and Mdm2 transgenics, although Mdm2 transgenic cells had more DNA breaks than their wild-type littermates at every age evaluated.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAs mice age, the number of metaphases with 50-80 chromosomes significantly increases in Mdm2 transgenic mice (p=0.04), but remains relatively constant in wild-type mice.
“As the mice aged, the number of metaphases with 50–80 chromosomes significantly increased in Mdm2 transgenic mice (p=0.04), but remained relatively constant for wild-type mice (Fig. 4D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCentromeric-telomeric fusions account for about a quarter of fusions, and telomeric-telomeric fusions are rare (<10%) in both genotypes.
“Centromeric-telomeric fusions accounted for a quarter of the fusions detected (Fig. 3C), and telomeric-telomeric fusions were rare for both genotypes and accounted for less than 10% of the fusions identified.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMdm2 overexpression leads to a greater frequency of gains of chromosomes compared to wild-type mice, and this increased with age.
“In contrast, Mdm2 overexpression led to a greater frequency of gains of chromosomes compared to the rate in wild-type mice, and this increased with age.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAs mice age, both wild-type and Mdm2 transgenic mice have increased numbers of metaphases with less than 40 chromosomes (p=0.003), doubling the mean frequency between 2 and 14 months.
“As mice aged, both wild-type and Mdm2 transgenic mice had increased numbers of metaphases with less than 40 chromosomes (p=0.003), doubling the mean frequency between 2 months and 14 months of age (Fig. 6A & 6B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAs mice age, the number of metaphases with greater than 40 chromosomes slightly increases in wild-type mice, but this increase is not significant (p=0.34).
“However, as the mice aged, the number of metaphases with greater than 40 chromosomes slightly increased in wild-type mice, but this increase was not significant (p=0.34).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMdm2 transgenic mice have both increased polyploid and aneuploid cells that correlate with age.
“Notably, Mdm2 transgenic mice had both increased polyploid and aneuploid cells that correlated with age.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt 2 months of age, wild-type and Mdm2 transgenic mice have a similar low number of metaphases with fused chromosomes, and both genotypes show an increase in metaphases with fused chromosomes as they age.
“At 2 months of age, wild-type and Mdm2 transgenic mice had a similar low number of metaphases with fused chromosomes, and both genotypes showed an increase in metaphases with fused chromosomes as the mice aged (Fig. 3D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMdm2 transgenic mice have a greater percentage of metaphases with fused chromosomes than wild-type mice, with the greatest difference at older ages (p=0.05).
“However, Mdm2 transgenic mice had a greater percentage of metaphases with fused chromosomes than wild-type mice with the greatest difference detected at older ages (p=0.05) (Fig. 3E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataChromosomal fusions are rare but occur in both wild-type and Mdm2 transgenic mice.
“Although fusions were rare, they were identified in both wild-type and Mdm2 transgenic mice (Fig. 3A–3C).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataRing chromosomes are observed in Mdm2 transgenic mice as young as 5 months and in 14-month-old mice.
“Additionally, a very rare fusion, a ring chromosome, was observed in cells from Mdm2 transgenic mice as young as 5 months old and in 14 month old mice (Fig. 3G).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe number of metaphases with greater than 40 chromosomes profoundly increases with age in Mdm2 transgenic mice and is statistically significant (p=0.003).
“In contrast, the number of metaphases with greater than 40 chromosomes profoundly increased with age in Mdm2 transgenic mice and was statistically significant (p=0.003) (Fig. 6D).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMdm2 overexpression in primary fibroblasts causes an Nbs1-dependent delay in DNA double-strand break repair, leading to longer-persisting breaks and increased chromatid and chromosome breaks.
“Previously we reported that Mdm2 overexpression in primary fibroblasts results in an Nbs1-dependent delay in DNA double-strand break repair, resulting in DNA breaks persisting longer and an increase in chromatid and chromosome breaks (Alt et al., 2005, Bouska et al., 2008).”
Quote in the paperSubstantial claim0 of 2 sources checkedClassified as probably not a substantial claim. May combine two claims.
PremisecitationDNA breaks can be substrates for fusions and translocations of chromosomes, which can accumulate in aging mice.
“DNA breaks can be substrates for fusions and translocations of chromosomes (Morgan et al., 1998), which can accumulate in aging mice (Dolle and Vijg, 2002).”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAneuploidy frequently arises due to defects in chromosome segregation during mitosis.
“Aneuploidy frequently arises due to defects in chromosome segregation during mitosis (Thompson et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Thompson et al., 2010
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationPolyploidy is considered a prerequisite to aneuploidy.
“Polyploidy is considered a prerequisite to aneuploidy (Fujiwara et al., 2005, Ganem et al., 2007, Storchova and Kuffer, 2008, Thompson et al., 2010, Vitale et al., 2010)”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
Interpretationown dataAge has little effect on the development of polyploidy in wild-type mice, but elevated Mdm2 significantly increases the rate of emergence of polyploid cells in mice over 14 months.
“Our results indicate that age had little effect on the development of polyploidy in wild-type mice, but elevated levels of Mdm2 significantly increased the rate of emergence of polyploid cells in mice over 14 months.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMdm2 overexpression exacerbates the rate of chromosome gains but not chromosome losses.
“However, Mdm2 overexpression only resulted in an exacerbation of the rate of gains in chromosomes and not in the loss of chromosomes.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataAs wild-type and Mdm2 transgenic mice age, both gains and losses of chromosomes increase.
“These data indicate that as wild-type and Mdm2 transgenic mice age, both gains and losses of chromosomes increased.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThis study shows that specific numerical and structural chromosomal changes increase with age in wild-type C57Bl/6 mice and are exacerbated by Mdm2 overexpression.
“This study shows that specific numerical and structural chromosomal changes increased with age in wild-type C57Bl/6 mice and were exacerbated with Mdm2 overexpression.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataAs mice age, the frequency of chromosome instability increases, and elevated Mdm2 significantly augments this increase.
“Therefore, as mice age, the frequency of CIN increases, and this is significantly augmented by elevated levels of Mdm2.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMdm2 overexpression increases the frequency of chromosome and chromatid breaks at every age evaluated, but does not accelerate the rate at which breaks occur with age.
“Therefore, although Mdm2 overexpression increased the frequency of chromosome and chromatid breaks at every age evaluated, Mdm2 overexpression did not accelerate the rate at which breaks occurred with age.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataGenome instability precedes tumorigenesis and likely contributes to the development of tumors.
“indicating genome instability precedes tumorigenesis and likely contributes to the development of tumors.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMdm2 expression can lead to degradation of p21, and loss of p21 results in endoreduplication and polyploid cells.
“Moreover, Mdm2 expression can lead to the degradation of the p53 transcriptional target gene and cell cycle inhibitor p21, and loss of p21 results in endoreduplication and polyploid cells (Jin et al., 2003, Stewart et al., 1999).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Interpretationown dataMdm2 transgenic mice have greatly increased and more severe chromosomal alterations than wild-type mice that correlate with age.
“Moreover, Mdm2 transgenic mice had greatly increased and more severe chromosomal alterations than wild-type mice that correlated to age”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataFused chromosomes are more common in Mdm2 transgenic mice; prevalence increases with age in both genotypes, but the rate of increase is greater for Mdm2 transgenic mice, suggesting an interaction between Mdm2 and age on chromosomal fusions.
“Therefore, fused chromosomes were more common in Mdm2 transgenic mice. The prevalence of these abnormalities increased with age in both wild-type and Mdm2 transgenic mice, but the rate of increase was greater for Mdm2 transgenic mice, suggesting an interaction between Mdm2 and age on chromosomal fusions.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningElevated Mdm2 expression over time increases fusion events, possibly due to increased total breaks but possibly also other uncharacterized mechanisms.
“Thus, elevated expression of Mdm2 over time increased fusion events, which may be due to the increase in total overall breaks in the cells of these mice, but may also be due to other uncharacterized mechanisms.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataGEE models gave results very similar to negative binomial regression models.
“These models gave results that were very similar to those obtained from our negative binomial regression models.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataStatistical models included an interaction term between genotype and age.
“An interaction term between genotype and age at sacrifice was included in this model.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataProlonged Mdm2 overexpression worsens the genomic abnormalities observed over time, and chromosomal alterations accumulate with age prior to tumor development.
“Here our data reveal that prolonged Mdm2 overexpression worsens the genomic abnormalities observed over time, and that chromosomal alterations accumulate with age prior to tumor development.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe chromosomal structure of three chromosomes fused centromere to telomere is typical of a breakage-fusion-bridge cycle that can lead to gene amplifications or translocations and is associated with tumorigenesis.
“The chromosomal structure of three chromosomes fused centromere to telomere is typical of a breakage-fusion-bridge cycle that can lead to gene amplifications or translocations and is associated with tumorigenesis (DePinho and Polyak, 2004).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites DePinho and Polyak, 2004 source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenOnly breaks visible by both PI and DAPI staining were scored as breaks.
“Only breaks visible by both PI and DAPI staining were scored as a break.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationStudies have shown age-related changes in DNA repair mechanisms.
“Studies using a variety of techniques have shown age-related changes in DNA repair mechanisms (Gorbunova et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gorbunova et al., 2007 source
Not checked in the free run.
May combine two claims.
PremisecitationSignaling from ATM and the response of other DNA repair proteins declines with age.
“For example, signaling from the DNA damage kinase, ATM, and the response of other DNA repair proteins declines with age (Feng et al., 2007, Gorbunova et al., 2007).”
Quote in the paperSubstantial claim0 of 2 sources checkedClassified as probably not a substantial claim.
Study design and conductown dataThe study used littermate-matched wild-type and Mdm2 transgenic mice.
“Experimental mice were generated by breeding hemizygous Mdm2 transgenic males to C57Bl/6 females to generate hemizygous Mdm2 transgenic mice and wild-type littermate controls.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataMice with overt cancer or suspected malignancy were excluded from the study.
“Tissues from each mouse were carefully evaluated for malignancies; any mouse with overt cancer or suspected of having a malignancy were excluded from the study.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMdm2 negatively regulates both p53 and mediators of ATM activation, the Mre11/Rad50/Nbs1 DNA repair complex.
“Mdm2 negatively regulates both p53 and mediators of ATM activation, the Mre11/Rad50/Nbs1 DNA repair complex (Alt et al., 2005, Bouska et al., 2008, Marine and Lozano, 2010).”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningMice older than 14 months were excluded due to tumor development in Mdm2 transgenic mice.
“Mice greater than 14 moths old were excluded from the study due to tumor development in Mdm2 transgenic mice.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataSlides were blinded before metaphase visualization and scoring.
“Slides were mounted with Vectashield (Vector Laboratories, Burlingame, CA), blinded, and 48–52 metaphases for each mouse for each genotype for each age were visualized and then photographed”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningMdm2 overexpression should both induce and allow chromosomal aberrations to accumulate over a lifetime, ultimately leading to cellular transformation and tumorigenesis.
“Thus, Mdm2 overexpression should both induce and allow chromosomal aberrations to accumulate in cells over the course of a lifetime, ultimately leading to cellular transformation and tumorigenesis.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationNegative binomial regression was used to model event rates.
“Negative binomial regression was used to model the event rates (the proportion of metaphase cells with the genetic abnormality of interest) in terms of genotype and age at sacrificed was performed (Agresti, 2002).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Agresti, 2002 source
Not checked in the free run.
May combine two claims.
PremisecitationA reduction in ATM and p53 function results in decreased DNA repair, reduced apoptosis, and an increase in CIN and tumorigenesis.
“A reduction in ATM and p53 function results in decreased DNA repair, reduced apoptosis, and an increase in CIN and tumorigenesis (Negrini et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Negrini et al., 2010 source
Not checked in the free run.
The paper relies on this without support.
Mdm2 transgenic mice develop cancer earlier than wild-type mice, and wild-type mice may never develop malignancy.
“they also develop cancer significantly earlier in life than wild-type mice, which may never develop a malignancy.”
The paper relies on this without support.
Mouse aging is a valid model for mammalian aging.
“whether elevated levels of Mdm2 affect chromosomal stability as a mammal ages is unknown.”
The paper relies on this without support.
Splenocytes are representative of organism-wide chromosomal instability.
“approximately 3,600 metaphase spreads of splenocytes from 72 littermate-matched pre-cancerous wild-type C57Bl/6 and Mdm2 hemizygous transgenic mice 2–14 months old were analyzed for chromosomal alterations.”
The paper relies on this without support.
Mdm2 transgenic mice without overt tumors are pre-cancerous.
“pre-cancerous wild-type C57Bl/6 and littermate-matched Mdm2 transgenic mice at various ages were evaluated.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mdm2 overexpression leads to genome instability in vivo and in vitro regardless of p53 status.
“Mdm2 overexpression regardless of p53 status leads to genome instability in vivo and in vitro”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Lushnikova, et al., 2011
These chromosome abnormalities are also found in cells that overexpress Mdm2 and lack p53.
“these abnormalities have also been detected in cells overexpressing Mdm2 and lacking p53”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Lushnikova, et al., 2011
Elevated Mdm2 levels increase chromatid and chromosome breaks and fusions.
“Elevated levels of Mdm2 result in increased chromatid and chromosome breaks as well as fusions”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Lushnikova, et al., 2011
Cites
Everitt, B. S. (2001) · Psychology Press eBooks · doi:10.4324/9781410605542-11 · Cited by 6,877 · see citing works
Agresti, A. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/0471249688 · Cited by 6,746 · see citing works
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 8× · see citing works
“somes (aneuploidy or polyploidy) and/or in the structure of chromosomes (breaks, fusion, insertions, deletions and translocations; Lengauer et al., 1998; Negrini et al., 2010).”
BackgroundInfluentialDiggle, P. J., Heagerty, P. J., Liang, K., & Zeger, S. L. (2002) · doi:10.1093/oso/9780198524847.001.0001 · Cited by 3,388 · see citing works
Genomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397 · see citing works
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967 · see citing works
Aubert, G., & Lansdorp, P. M. (2008) · Physiological Reviews · doi:10.1152/physrev.00026.2007 · Cited by 1,188 · see citing works
Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells
Fujiwara, T., Bandi, M., Nitta, M., Ivanova, E. V., Bronson, R. T., & Pellman, D. (2005) · Nature · doi:10.1038/nature04217 · Cited by 1,067 · see citing works
Tetraploidy, aneuploidy and cancer
Ganem, N. J., Storchova, Z., & Pellman, D. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.02.011 · Cited by 668 · see citing works
Mechanisms of Chromosomal Instability
Thompson, S. L., Bakhoum, S. F. W., & Compton, D. A. (2010) · Current Biology · doi:10.1016/j.cub.2010.01.034 · Cited by 600 · see citing works
Proliferation of aneuploid human cells is limited by a p53-dependent mechanism
Thompson, S. L., & Compton, D. A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200905057 · Cited by 494 · see citing works
Changes in DNA repair during aging
Gorbunova, V., Seluanov, A., Mao, Z., & Hine, C. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm756 · Cited by 405 · see citing works
Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis
Jones, S. N., Hancock, A. R., Vogel, H., Donehower, L. A., & Bradley, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15608 · Cited by 386 · see citing works
DNA damage and ageing: new-age ideas for an age-old problem
Garinis, G. A., van der Horst, G. T. J., Vijg, J., & H.J. Hoeijmakers, J. (2008) · Nature Cell Biology · doi:10.1038/ncb1108-1241 · Cited by 366 · see citing works
The consequences of tetraploidy and aneuploidy
Storchova, Z., & Kuffer, C. (2008) · Journal of Cell Science · doi:10.1242/jcs.039537 · Cited by 363 · see citing works
Mdm2-mediated ubiquitylation: p53 and beyond
Marine, J.-C., & Lozano, G. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.68 · Cited by 354 · see citing works
Carroll, P. E., Okuda, M., Horn, H. F., Biddinger, P., Stambrook, P. J., Gleich, L. L., Li, Y.-Q., Tarapore, P., & Fukasawa, K. (1999) · Oncogene · doi:10.1038/sj.onc.1202515 · Cited by 279 · see citing works
Rayburn, E., Zhang, R., He, J., & Wang, H. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053332636 · Cited by 265 · see citing works
Feng, Z., Hu, W., Teresky, A. K., Hernando, E., Cordon-Cardo, C., & Levine, A. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708043104 · Cited by 264 · see citing works
Lundgren, K., Montes de Oca Luna, R., McNeill, Y. B., Emerick, E. P., Spencer, B., Barfield, C. R., Lozano, G., Rosenberg, M. P., & Finlay, C. A. (1997) · Genes & Development · doi:10.1101/gad.11.6.714 · Cited by 235 · see citing works
Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models
Difilippantonio, S., Celeste, A., Fernandez-Capetillo, O., Chen, H.-T., Martin, B. R. S., Laethem, F. V., Yang, Y.-P., Petukhova, G. V., Eckhaus, M., Feigenbaum, L., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1270 · Cited by 227 · see citing works
A Murine Model of Nijmegen Breakage Syndrome
Williams, B. R., Mirzoeva, O. K., Morgan, W. F., Lin, J., Dunnick, W., & Petrini, J. H. J. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00763-7 · Cited by 208 · see citing works
MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation
Jin, Y., Lee, H., Zeng, S. X., Dai, M., & Lu, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg600 · Cited by 206 · see citing works
Stewart, Z. A., Leach, S. D., & Pietenpol, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.205 · Cited by 168 · see citing works
Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos
Vitale, I., Senovilla, L., Jemaà, M., Michaud, M., Galluzzi, L., Kepp, O., Nanty, L., Criollo, A., Rello‐Varona, S., Manic, G., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.11 · Cited by 146 · see citing works
Mdm2 Binds to Nbs1 at Sites of DNA Damage and Regulates Double Strand Break Repair
Alt, J. R., Bouska, A., Fernandez, M. R., Cerny, R. L., Xiao, H., & Eischen, C. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413387200 · Cited by 131 · see citing works
Self-citationPericentromeric organization at the fusion point of mouse Robertsonian translocation chromosomes
Garagna, S., Marziliano, N., Zuccotti, M., Searle, J. B., Capanna, E., & Redi, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.171 · Cited by 129 · see citing works
Mdm2 Promotes Genetic Instability and Transformation Independent of p53
Bouska, A., Lushnikova, T., Plaza, S., & Eischen, C. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01584-07 · Cited by 105 · see citing works
Self-citationDNA double-strand breaks, chromosomal rearrangements, and genomic instability
Morgan, W. F., Corcoran, J., Hartmann, A., Kaplan, M. I., Limoli, C. L., & Ponnaiya, B. (1998) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(98)00104-3 · Cited by 105 · see citing works
Polyploids require Bik1 for kinetochore–microtubule attachment
Lin, H., Carvalho, P., Kho, D., Tai, C., Pierre, P., Fink, G. R., & Pellman, D. S. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200108119 · Cited by 102 · see citing works
DePinho, R. A., & Polyak, K. (2004) · Nature Genetics · doi:10.1038/ng0904-932 · Cited by 91 · see citing works
SV40 T antigen interacts with Nbs1 to disrupt DNA replication controlPreprint
Wu, X., Avni, D., Chiba, T., Yan, F., Zhao, Q., Lin, Y., Heng, H., & Livingston, D. (2004) · Genes & Development · doi:10.1101/gad.1182804 · Cited by 88 · see citing works
Wang, P., Lushnikova, T., Odvody, J., Greiner, T. C., Jones, S. N., & Eischen, C. M. (2008) · Oncogene · doi:10.1038/sj.onc.1210788 · Cited by 86 · see citing works
Self-citationDemuth, I., & Digweed, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210876 · Cited by 77 · see citing works
Frequency of spontaneous chromosome aberrations in mice: effects of age
Tucker, J. D., Spruill, M., Ramsey, M. J., Director, A. D., & Nath, J. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00036-6 · Cited by 71 · see citing works
Mdm2 affects genome stability independent of p53
Bouska, A., & Eischen, C. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3732 · Cited by 71 · see citing works
Self-citationDollé, M. E. T., & Vijg, J. (2002) · Genome Research · doi:10.1101/gr.125502 · Cited by 66 · see citing works
Cytogenetic perspective of ageing and longevity in men and women
Ziętkiewicz, E., Wojda, A., & Witt, M. (2009) · Journal of Applied Genetics · doi:10.1007/bf03195682 · Cited by 50 · see citing works
Acceleration of chromosome aberrations in senescence-accelerated strains of mice
Nisitani, S., Hosokawa, M., Sasaki, M. S., Yasuoka, K., Naiki, H., Matsushita, T., & Takeda, T. (1990) · Mutation Research/DNAging · doi:10.1016/0921-8734(90)90003-a · Cited by 47 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan
Baker, D. J., Dawlaty, M. M., Wijshake, T., Jeganathan, K. B., Malureanu, L. A., van Ree, J. H., Crespo‐Diaz, R. J., Reyes, S., Seaburg, L., Shapiro, V. S., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2643 · Cited by 272 · see citing works
Eischen, C. M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026096 · Cited by 161 · see citing works
Self-citationAging and radiation: bad companions
Hernández, L., Terradas, M., Camps, J., Martı́n, M., Tusell, L., & Genescà, A. (2015) · Aging Cell · doi:10.1111/acel.12306 · Cited by 89 · see citing works
Chromosomal instability: A common feature and a therapeutic target of cancer
Tanaka, K., & Hirota, T. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.06.002 · Cited by 81 · see citing works
The Mdm network and its regulation of p53 activities: a rheostat of cancer risk
Eischen, C. M., & Lozano, G. (2014) · Human Mutation · doi:10.1002/humu.22524 · Cited by 79 · see citing works
Self-citationCIN and Aneuploidy: Different Concepts, Different Consequences
Schukken, K. M., & Foijer, F. (2017) · BioEssays · doi:10.1002/bies.201700147 · Cited by 61 · see citing works
Telomere function and regulation from mouse models to human ageing and disease
Jones-Weinert, C. W., Mainz, L., & Karlseder, J. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00800-5 · Cited by 57 · see citing works
Tarabichi, M., Antoniou, A., Saiselet, M., Pita, J. M. G., Andry, G., Dumont, J. E., Detours, V., & Maenhaut, C. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9431-y · Cited by 50 · see citing works
Role of Mdm2 and Mdmx in DNA repair
Eischen, C. M. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw052 · Cited by 45 · see citing works
Self-citationAnatomy of Mdm2 and Mdm4 in evolution
Tan, B. X., Liew, H. P., Chua, J. S., Ghadessy, F. J., Tan, Y. S., Lane, D. P., & Coffill, C. R. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx002 · Cited by 40 · see citing works
Splicing Up Mdm2 for Cancer Proteome Diversity
Okoro, D. R., Rosso, M., & Bargonetti, J. (2012) · Genes & Cancer · doi:10.1177/1947601912455323 · Cited by 36 · see citing works
Li, W., Peng, X., Lang, J., & Xu, C. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00631 · Cited by 36 · see citing works
Chromosomal Instability in Acute Myeloid Leukemia
Lisboa, M. D. O., Brofman, P. R. S., Schmid-Braz, A. T., Pozzo, A. R., & Mai, S. (2021) · Cancers · doi:10.3390/cancers13112655 · Cited by 33 · see citing works
Aneuploidy shortens replicative lifespan in Saccharomyces cerevisiae
Sunshine, A. B., Ong, G. T., Nickerson, D. P., Carr, D. T., Murakami, C. J., Wasko, B. M., Shemorry, A., Merz, A. J., Kaeberlein, M. R., & Dunham, M. J. (2016) · Aging Cell · doi:10.1111/acel.12443 · Cited by 29 · see citing works
Wang, S., Huang, J., Li, C., Zhao, L., Wong, C. C., Zhai, J., Zhou, Y., Deng, W., Zeng, Y., Gao, S., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1611 · Cited by 24 · see citing works
Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?
Beurlet, S., Chomienne, C., & Padua, R. A. (2012) · Haematologica · doi:10.3324/haematol.2012.069385 · Cited by 22 · see citing works
Distinct genomic profile in h. pylori ‐associated gastric cancer
Zhang, X., Liu, F., Bao, H., Wang, A., Han, M., Wu, X., Gu, Y., & Zheng, L. (2021) · Cancer Medicine · doi:10.1002/cam4.3765 · Cited by 21 · see citing works
Protecting the genome from mdm2 and mdmx
Melo, A. N., & Eischen, C. M. (2012) · Genes & Cancer · doi:10.1177/1947601912454139 · Cited by 20 · see citing works
Self-citationRiley, M. F., You, M. J., Multani, A. S., & Lozano, G. (2015) · Oncogene · doi:10.1038/onc.2015.88 · Cited by 19 · see citing works
Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age
Fontebasso, A. M., Shirinian, M., Khuong-Quang, D.-A., Béchet, D., Gayden, T., Kool, M., Jay, N. D., Jacob, K., Gerges, N., Hutter, B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5571 · Cited by 18 · see citing works
Modulation of the p53 family network by RNA-binding proteins
Lucchesi, C. A., Zhang, J., & Chen, X. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.08.30 · Cited by 17 · see citing works
MDM2 Overexpression, Activation of Signaling Networks, and Cell Proliferation
Deb, S. P., Singh, S., & Deb, S. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_12 · Cited by 17 · see citing works
Fine, R. D., Maqani, N., Li, M., Franck, E., & Smith, J. S. (2019) · Genetics · doi:10.1534/genetics.119.302047 · Cited by 16 · see citing works
The Causes and Consequences of Aneuploidy in Eukaryotic Cells
Štorchová, Z. (2012) · InTech eBooks · doi:10.5772/45781 · Cited by 15 · see citing works
Lee, K., Lau, Z. Z., Meredith, C., & Park, J. H. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.11.001 · Cited by 14 · see citing works
Chen, G., Li, Z., Iemura, K., & Tanaka, K. (2023) · Journal of Cell Science · doi:10.1242/jcs.260688 · Cited by 12 · see citing works
Lorenzini, A., Fink, L. S., Stamato, T. D., Torres, C. A., & Sell, C. (2011) · Aging · doi:10.18632/aging.100416 · Cited by 9 · see citing works
Xiaoli, L., Hu, F., Shihui, H., Niu, X., Li, S., Zhou, W., Xueqin, R., & Jia-fu, W. (2021) · Aging · doi:10.18632/aging.203711 · Cited by 8 · see citing works
Fraser, C. G. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.10.22 · Cited by 8 · see citing works
Malakar, P. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1410308 · Cited by 4 · see citing works
Malarvizhi, G. L., & Bayry, J. (2025) · The FASEB Journal · doi:10.1096/fj.202501100r · Cited by 3 · see citing works
González, P. O., Teal, A., Chellaganapathy, L., Ramı́rez, G., Pianeta, R., Segvich, D. M., Liu, Z., Wallace, J. M., & Plotkin, L. I. (2026) · Bone · doi:10.1016/j.bone.2026.117785 · Cited by 2 · see citing works
Pterostilbene enhances reproductive outcomes and oocyte quality in aged mice without adverse effects
Okamoto, N., Sato, Y., Kawagoe, Y., & Kawamura, K. (2025) · Aging · doi:10.18632/aging.206287 · Cited by 1 · see citing works
Zhu, K., Chen, G., Ren, Y., Iemura, K., & Tanaka, K. (2025) · npj Aging · doi:10.1038/s41514-025-00299-w · Cited by 1 · see citing works
"Dark matter of genome” in cancer
Lushnikova, T. (2019) · Journal of Cancer Prevention & Current Research · doi:10.15406/jcpcr.2019.10.00385
Self-citationThe tumour suppressor p53 as a supporter of DNA replication
Klusmann, I. (2018) · doi:10.53846/goediss-7143
Non-canonical functions of the MDM2 oncoprotein
Manzini, V. (2022) · doi:10.53846/goediss-9537
37 kDa LRP::FLAG enhances telomerase activity and reduces ageing markers in vivo
Otgaar, T. C., Bernert, M., Morris, G., Baichan, P., Bignoux, M. J., Letsolo, B. T., Weiss, S. F. T., & Ferreira, E. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05593-0
Lin, F.-W., Zhao, M.-Q., Wu, Q., Wu, W., Wu, X.-Y., Ma, Y., Yin, J.-N. C., Yang, M., & Gao, M. (2025) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.70088 · Cited by 1 · see citing works
- Authors
- Lushnikova, T., Bouska, A., Odvody, J., Dupont, W. D., & Eischen, C. M.
- Affiliations
- Vanderbilt University (US)
- University of Nebraska Medical Center (US)
- Corresponding author
- Eischen, C M
- Venue
- Oncogene
- Published
- 2011-05-23
- Volume
- 30
- Issue
- 46
- Pages
- 4622-4631
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- PMC
- PMC3161162
- OpenAlex
- W2002656606
- Semantic Scholar
- edeb2d5eb449cf5e61c4ce4c8424ac68d55fbf32
- Cited by
- 40
- References
- 39
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 6 · 2015: 3 · 2014: 3 · 2013: 1 · 2012: 6
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Vanderbilt University
- National Cancer Institute (R01CA117935, P30CA068485)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Keywords
- aging, chromosomal instability, MDM2, genomic instability, aneuploidy, chromosome fusion, polyploidy, chromatid breaks, p53, DNA repair, transgenic mice, precancerous cells, carcinogenesis, chromosomal abnormalities
- MeSH terms
- Aging, Animals, Gene Expression Regulation, Humans, Mice, Transgenic, Polyploidy, Precancerous Conditions, Chromosomal Instability, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-08.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-08.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review